These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Treatment of acute schizophrenia with sulforidazine]. Sánchez E; Ning JL; Núñez H; Medina E Rev Neuropsiquiatr; 1975 Jun; 38(2):94-105. PubMed ID: 1839 [No Abstract] [Full Text] [Related]
3. Accessing health care professionals about antipsychotic medication related concerns. Boardman GH; McCann TV; Clark E Issues Ment Health Nurs; 2008 Jul; 29(7):739-54. PubMed ID: 18592424 [TBL] [Abstract][Full Text] [Related]
4. Piperacetazine vs. thioridazine for the control of schizophrenia in outpatients. Rada RT; Donlon PT Psychosomatics; 1972; 13(6):373-6. PubMed ID: 4153002 [No Abstract] [Full Text] [Related]
5. Neuroleptic blood levels in outpatient maintenance therapy of schizophrenia. Sajadi C; Smith RC; Shvartsburd A; Morton V; Mirabi M; Gordon J Psychopharmacol Bull; 1984; 20(1):110-3. PubMed ID: 6144129 [No Abstract] [Full Text] [Related]
7. The effectiveness of guideline implementation strategies on improving antipsychotic medication management for schizophrenia. Owen RR; Hudson T; Thrush C; Thapa P; Armitage T; Landes RD Med Care; 2008 Jul; 46(7):686-91. PubMed ID: 18580387 [TBL] [Abstract][Full Text] [Related]
8. Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia. Loosbrock DL; Zhao Z; Johnstone BM; Morris LS J Ment Health Policy Econ; 2003 Jun; 6(2):67-75. PubMed ID: 14578539 [TBL] [Abstract][Full Text] [Related]
10. Restricting the use of thioridazine. Bailey P; Russell V Br J Gen Pract; 2002 Jun; 52(479):499-500. PubMed ID: 12051223 [No Abstract] [Full Text] [Related]
11. [Comparative evaluation of clinical practice guidelines for the treatment of schizophrenia]. Delessert D; Pomini V; Grasset F; Baumann P Encephale; 2008 Jan; 34(1):93-100. PubMed ID: 18514156 [TBL] [Abstract][Full Text] [Related]
12. [Reaction to "A critical analysis about the diagnostic choice for schizophrenia as starting point of practice guidelines for treatment"]. Dormaar JM Tijdschr Psychiatr; 2006; 48(3):249; author reply 249-50. PubMed ID: 16956090 [No Abstract] [Full Text] [Related]
13. Impact of the CSM advice on thioridazine on general practitioner prescribing behaviour in Leeds: time series analysis. Wright NM; Roberts AJ; Allgar VL; Tompkins CN; Greenwood DC; Laurence G Br J Gen Pract; 2004 May; 54(502):370-3. PubMed ID: 15113522 [TBL] [Abstract][Full Text] [Related]
14. Associations between adherence to guidelines for antipsychotic dose and health status, side effects, and patient care experiences. Dickey B; Normand SL; Eisen S; Hermann R; Cleary P; Cortés D; Ware N Med Care; 2006 Sep; 44(9):827-34. PubMed ID: 16932134 [TBL] [Abstract][Full Text] [Related]
15. [Attempt at the prevention of schizophrenic attacks. Observations during long-term medication with Melleril]. Radmayr E Wien Med Wochenschr; 1967 Oct; 117(40):906-9. PubMed ID: 5593740 [No Abstract] [Full Text] [Related]
16. Real-world antipsychotic treatment practices. Moore TA; Covell NH; Essock SM; Miller AL Psychiatr Clin North Am; 2007 Sep; 30(3):401-16. PubMed ID: 17720029 [TBL] [Abstract][Full Text] [Related]
17. [Sonapax use in the clinical practice]. Siriachenko TM; Mikhaĭlova NM Voen Med Zh; 2005 Apr; 326(4):26-34. PubMed ID: 15962598 [No Abstract] [Full Text] [Related]
18. Schizophrenia practice guideline. Liberman RP Am J Psychiatry; 1997 Dec; 154(12):1792-3; author reply 1793-4. PubMed ID: 9396968 [No Abstract] [Full Text] [Related]
19. Recommendations from treatment guidelines for schizophrenia regarding monitoring of side effects of antipsychotics: brief review. Kozumplik O; Uzun S Psychiatr Danub; 2009 Mar; 21(1):95-8. PubMed ID: 19270630 [TBL] [Abstract][Full Text] [Related]